What happened
Kumho Engineering & Construction updated a previously disclosed supply contract with Daewoong Pharma, now worth US$102M, about 7.51% of its recent annual revenue, running through May 2026.
For context, this single contract equals about 7.51% of the company's most recent annual revenue.
| Counterparty | Daewoong Pharma |
|---|---|
| Contract value | US$102M |
| vs. recent revenue | 7.51% |
| Through | May 2026 (from Apr 2024) |
| Filed | 2026-05-21, [Amended] Supply contract signed |
| Source | DART rcept 20260521800619 → open original filing |
Source: DART. Information only, not investment advice.